Evidence map›Paper›PMID 25277522›Full record

ArticleNature communications2014

An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability.

Hong-Bo Pang, Gary B Braun, Tomas Friman, Pedro Aza-Blanc, Manuel E Ruidiaz, Kazuki N Sugahara, Tambet Teesalu, Erkki Ruoslahti

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 190 citations in OpenAlex.

  1. Article
  2. Article
  3. An effective tumor-inhibiting siRNA delivery platform.Biochemical and biophysical research communications · 2026
    Article
  4. Review
  5. miRNA family miR-29 inhibits PINK1-PRKN signaling via ATG9A.Molecular neurodegeneration advances · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Advancing Cancer-Targeted Nanotherapies with Tumor Homing Peptides.ACS pharmacology & translational science · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Theranostic Fluorescent Probes.Chemical reviews · 2024
    Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hong-Bo PangCancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA.
Gary B Braun1] Cancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA [2] Center for Nanomedicine, Department of Cell, Molecular and Developmental Biology, University of California Santa Barbara, Santa Barbara, California 93106-9610, USA.
Tomas Friman1] Cancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA [2] Center for Nanomedicine, Department of Cell, Molecular and Developmental Biology, University of California Santa Barbara, Santa Barbara, California 93106-9610, USA.
Pedro Aza-BlancCancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA.
Manuel E RuidiazCancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA.
Kazuki N Sugahara1] Cancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA [2] Department of Surgery, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.
Tambet Teesalu1] Cancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA [2] Laboratory of Cancer Biology, Institute of Biomedicine and Translational Medicine, Centre of Excellence for Translational Medicine, University of Tartu, 50411 Tartu, Estonia.
Erkki Ruoslahti1] Cancer Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA [2] Center for Nanomedicine, Department of Cell, Molecular and Developmental Biology, University of California Santa Barbara, Santa Barbara, California 93106-9610, USA.
Cancer Research Center · USSanford Burnham Prebys Medical Discovery Institute · USUniversity of California, Santa Barbara · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
Tumor Penetrating Peptides for Cancer TargetingR01CA152327 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RUOSLAHTI, ERKKI · 2011 to 2015
$2.0M
Trans-disciplinary Postdoctoral Training in Cancer BiologyT32CA121949 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RONAI, ZEEV A. · 2007 to 2011
$1.8M
NCI NIH HHS CA152327NCI NIH HHS CA30199NCI NIH HHS P30 CA030199NCI NIH HHS R01 CA152327NCI NIH HHS T32 CA121949
6 · The paper itself

Abstract

Neuropilins (NRPs) are trans-membrane receptors involved in axon guidance and vascular development. Many growth factors and other signalling molecules bind to NRPs through a carboxy (C)-terminal, basic sequence motif (C-end Rule or CendR motif). Peptides with this motif (CendR peptides) are taken up into cells by endocytosis. Tumour-homing CendR peptides penetrate through tumour tissue and have shown utility in enhancing drug delivery into tumours. Here we show, using RNAi screening and subsequent validation studies, that NRP1-mediated endocytosis of CendR peptides is distinct from known endocytic pathways. Ultrastructurally, CendR endocytosis resembles macropinocytosis, but is mechanistically different. We also show that nutrient-sensing networks such as mTOR signalling regulate CendR endocytosis and subsequent intercellular transport of CendR cargo, both of which are stimulated by nutrient depletion. As CendR is a bulk transport pathway, our results suggest a role for it in nutrient transport; CendR-enhanced drug delivery then makes use of this natural pathway.

Indexed as

EndocytosisAmino Acid MotifsAnimalsDrug Delivery SystemsFoodGoldHeLa CellsHumansHuman Umbilical Vein Endothelial CellsLigandsMaleMetal NanoparticlesMiceMicroscopy, FluorescenceNeoplasm TransplantationNeuropilin-1GoldLigandsNeuropilin-1PeptidesSilver

Identifiers

PMID25277522
PMCPMC4185402
OpenAlexW1981988157

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.